UC

Umesh Chandra Singh

Active Director Director DIN 10966779
DIN 10966779 First appointment Feb 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Umesh Chandra Singh

Data last updated:

Umesh Chandra Singh is a Director at Axpect Pharma Private Limited (since 2025). The company operates in Paper.

DIN 10966779
Primary Designation Director
Industry Paper
First Appointment 24 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axpect Pharma Private Limited U21000UP2025PTC217415
Director24 Feb 20252025Active

Board colleagues of Umesh Chandra Singh

NameDINCompanyDesignation
Saurabh Singh10072454Axpect Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Axpect Pharma Private Limited
Premium access

Shareholding and investment profile for Umesh Chandra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umesh Chandra Singh

Umesh Chandra Singh currently holds 1 directorship: Axpect Pharma Private Limited (Director, since 24 Feb 2025).

Umesh Chandra Singh was first appointed on 24 Feb 2025 as Director at Axpect Pharma Private Limited.

The current boards of Umesh Chandra Singh's companies include Saurabh Singh (Axpect Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available